Guidelines from the 2017 European Conference on Infections in Leukaemia for management of HHV-6 infection in patients with hematologic malignancies and after hematopoietic stem cell transplantation

Ward KN, Hill JA, Hubacek P, De La Camara R, Crocchiolo R, Einsele H, Navarro D, Robin C, Cordonnier C, Ljungman P (2019)


Publication Type: Journal article, Review article

Publication year: 2019

Journal

Book Volume: 104

Pages Range: 2155-2163

Journal Issue: 11

DOI: 10.3324/haematol.2019.223073

Abstract

Of the two human herpesvirus 6 (HHV-6) species, human herpesvirus 6B (HHV-6B) encephalitis is an important cause of morbidity and mortality after allogeneic hematopoietic stem cell transplant. Guidelines for the management of HHV-6 infections in patients with hematologic malignancies or post-transplant were prepared a decade ago but there have been no other guidelines since then despite significant advances in the understanding of HHV-6 encephalitis, its therapy, and other aspects of HHV-6 disease in this patient population. Revised guidelines prepared at the 2017 European Conference on Infections in Leukaemia covering diagnosis, preventative strategies and management of HHV-6 disease are now presented.

Involved external institutions

How to cite

APA:

Ward, K.N., Hill, J.A., Hubacek, P., De La Camara, R., Crocchiolo, R., Einsele, H.,... Ljungman, P. (2019). Guidelines from the 2017 European Conference on Infections in Leukaemia for management of HHV-6 infection in patients with hematologic malignancies and after hematopoietic stem cell transplantation. Haematologica, 104(11), 2155-2163. https://doi.org/10.3324/haematol.2019.223073

MLA:

Ward, Katherine N., et al. "Guidelines from the 2017 European Conference on Infections in Leukaemia for management of HHV-6 infection in patients with hematologic malignancies and after hematopoietic stem cell transplantation." Haematologica 104.11 (2019): 2155-2163.

BibTeX: Download